EVOCellic is a ready-to-use cell therapy, developed for promoting accelerated wound regeneration, using specially activated cells, for burn and chronic wounded patients. Its freeze-dried formulation allows for easy storage, even at higher temperatures.
EVOLung represents a breakthrough approach to treating inhalation injuries — a critical medical challenge with limited therapeutic options and significant unmet clinical need.
EVOEye applies EVOCellic’s proprietary keratinocyte production technology to a new indication — the regeneration of the ocular surface following injury or disease.